Oric Pharmaceuticals Stock Investor Sentiment
| ORIC Stock | USD 10.42 0.35 3.25% |
About 84 percent of Oric Pharmaceuticals' shareholders are selling. The analysis of the overall investor sentiment regarding Oric Pharmaceuticals suggests that quite a large number of traders are terrified. The current market sentiment, together with Oric Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Oric Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
Oric |
Oric Pharmaceuticals Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Oric Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Oric Pharmaceuticals that are available to investors today. That information is available publicly through Oric media outlets and privately through word of mouth or via Oric internal channels. However, regardless of the origin, that massive amount of Oric data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Oric Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Oric Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Oric Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Oric Pharmaceuticals alpha.
Oric Pharmaceuticals Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | We Think ORIC Pharmaceuticals Can Afford To Drive Business Growth | 12/12/2024 |
2 | Disposition of 16667 shares by Chacko Jacob of Oric Pharmaceuticals subject to Rule 16b-3 | 12/13/2024 |
3 | Disposition of 24660 shares by Chacko Jacob of Oric Pharmaceuticals at 8.2812 subject to Rule 16b-3 | 12/16/2024 |
4 | Oric Pharmaceuticals CEO Chacko Jacob sells 204,214 in stock - Investing.com | 12/17/2024 |
5 | Acquisition by Chacko Jacob of 300000 shares of Oric Pharmaceuticals at 4.36 subject to Rule 16b-3 | 12/27/2024 |
6 | Acquisition by Chacko Jacob of 100000 shares of Oric Pharmaceuticals subject to Rule 16b-3 | 01/02/2025 |
7 | ORIC Pharmaceuticals Reports Inducement Grantsunder Nasdaq Listing Rule 5635 | 01/03/2025 |
8 | ORIC Pharmaceuticals to Present at the 43rd AnnualJ.P. Morgan Healthcare Conference | 01/06/2025 |
9 | PriceSmart Posts Weak Earnings, Joins Roku And Other Big Stocks Moving Lower In Fridays Pre-Market Session | 01/10/2025 |
10 | ORIC Pharmaceuticals Provides Early Phase 1b Combination Data for ORIC-944, Operational Highlights for 2024, and Anticipated Upcoming Milestones | 01/13/2025 |
11 | HE Equipment Services, ACM Research, Robinhood And Other Big Stocks Moving Higher On Tuesday | 01/14/2025 |
12 | ORIC Pharmaceuticals Overweight Rating Reaffirmed at Cantor Fitzgerald | 01/17/2025 |
13 | Acquisition by Kunkel Lori Anne of 25600 shares of Oric Pharmaceuticals at 7.9 subject to Rule 16b-3 | 01/27/2025 |
Complementary Tools for Oric Stock analysis
When running Oric Pharmaceuticals' price analysis, check to measure Oric Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oric Pharmaceuticals is operating at the current time. Most of Oric Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Oric Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oric Pharmaceuticals' price. Additionally, you may evaluate how the addition of Oric Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Stocks Directory Find actively traded stocks across global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |